Genmark Diagnostics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2020 to a ratio of 8.51, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the fourth quarter 2020. Average receivable collection period, for the Genmark Diagnostics Inc in Dec 31 2020 quarter, has decreased to 43 days, compared to 47 days, in the Sep 30 2020 quarter.

If we take a look into Healthcare sector 74 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 997, from overall ranking in the third quarter 2020 at 1527.

What is Receivable Turnover Ratio?
What is Genmark Diagnostics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GNMK Receivables Turnover Ratio	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter
Y / Y Receivable Change	24.05 %	55.35 %	164.46 %	180.55 %	45.3 %
Y / Y Revenue Change	84.14 %	103.87 %	118.17 %	79.92 %	40.34 %
Receivable Turnover Ratio (TTM)	8.51	7.77	7.17	7.05	8.16
GNMK's Total Ranking	# 997	# 1527	# 1500	# 1524	# 1524
Accounts Receivable average collection period days	43	47	51	52	45
Seq. Receivable Change	28.09 %	-9.16 %	-30.54 %	53.48 %	60.4 %
Seq. Revenue Change	17.43 %	6.39 %	3.47 %	42.45 %	30.01 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 34
Healthcare Sector	# 75
Overall Market	# 997

Receivable Turnover Ratio Statistics
High	Average	Low
1.06	0.59	0.22
(Mar 31 2020)		(Jun 30 2014)

GNMK Company Profile • Back to GNMK Efficiency Comparisons • Compare GNMK Receivables Turnover Ratio to its Competitors

Financial Statements
Genmark Diagnostics Inc 's Accounts Receivable	$ 21 Millions	Visit GNMK's Balance sheet
Genmark Diagnostics Inc 's Sales TTM	$ 172 Millions	Visit GNMK's Income Statement
Sources of GNMK's Revenues		Visit GNMK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GNMK's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GNMK's Growth Rates	GNMK's Roa	GNMK's Inventory Turnover Ratio	GNMK's Dividend Comparisons
GNMK's Profitability Ratios	GNMK's Roi	GNMK's Asset Turnover Ratio	GNMK's Dividend Growth
GNMK's Valuation Ratios	GNMK's Roe	GNMK's Financial Strength Ratios	GNMK's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2020	Receivable at quarter ending Dec 31 2020
Uniqure N v	22.67	$ 37.514 Millions	$ 1.655 Millions
Harrow Inc	21.95	$ 48.871 Millions	$ 2.226 Millions
Scorpius Holdings inc	21.04	$ 2.948 Millions	$ 0.140 Millions
Cardax Inc	20.81	$ 0.539 Millions	$ 0.026 Millions
Ethema Health Corporation	20.71	$ 0.339 Millions	$ 0.016 Millions
Advanced Container Technologies Inc	20.49	$ 2.228 Millions	$ 0.109 Millions
Dbv Technologies S a	20.23	$ 11.276 Millions	$ 0.558 Millions
Durect Corp	19.63	$ 30.111 Millions	$ 1.534 Millions
Fonar Corporation	19.49	$ 78.814 Millions	$ 4.043 Millions
Therapeutic Solutions International Inc	19.46	$ 0.063 Millions	$ 0.003 Millions
China Pharma Holdings Inc	19.37	$ 10.866 Millions	$ 0.561 Millions
Xenon Pharmaceuticals Inc	18.83	$ 32.166 Millions	$ 1.709 Millions
Cv Sciences Inc	18.81	$ 24.429 Millions	$ 1.299 Millions
Catalyst Pharmaceuticals Inc	18.65	$ 119.073 Millions	$ 6.385 Millions
Ascendis Pharma A	17.97	$ 7.787 Millions	$ 0.433 Millions
Ibio inc	17.76	$ 2.331 Millions	$ 0.131 Millions
Fulcrum Therapeutics Inc	17.65	$ 8.823 Millions	$ 0.500 Millions
Emmaus Life Sciences Inc	17.55	$ 23.167 Millions	$ 1.320 Millions
Delcath Systems Inc	17.51	$ 1.646 Millions	$ 0.094 Millions
Semler Scientific inc	17.50	$ 38.603 Millions	$ 2.207 Millions
Neurometrix Inc	16.76	$ 7.378 Millions	$ 0.440 Millions
Electrocore Inc	16.69	$ 3.496 Millions	$ 0.210 Millions
Chemed Corporation	16.48	$ 2,079.583 Millions	$ 126.218 Millions
Myomo Inc	16.46	$ 7.583 Millions	$ 0.461 Millions
Vbi Vaccines Inc	16.32	$ 1.061 Millions	$ 0.065 Millions
Rafael Holdings Inc	16.22	$ 4.476 Millions	$ 0.276 Millions
Agenus Inc	16.15	$ 88.170 Millions	$ 5.461 Millions
Avita Medical Inc	15.98	$ 17.917 Millions	$ 1.121 Millions
Cytokinetics Incorporated	15.57	$ 55.828 Millions	$ 3.586 Millions
Mannkind Corporation	15.56	$ 65.144 Millions	$ 4.188 Millions

Date modified: 2026-09-08T15:10:10+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.